Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
Thomas, Gary
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.
Cholesterol homeostasis in pathogenesis of DR
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cholesterol homeostasis in pathogenesis of DR
Biography
contributor
Principal Investigator
Overview
sponsor award id
R01EY025383
Time
start date
2015-09-01
end date
2025-08-31